Use of nonprescription medications for perceived cardiovascular health

American Journal of Preventive Medicine

Volumn 30, Issue 1, 2006, Pages 78-81

  Artz, Margaret B ^a,d   Harnack, Lisa J ^b   Duval, Susan J ^b   Armstrong, Chris ^b   Arnett, Donna K ^c   Luepker, Russell V ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; FATTY ACID; FISH OIL; HERBACEOUS AGENT; NON PRESCRIPTION DRUG; OMEGA 3 FATTY ACID;

ADULT; AGED; ATTITUDE TO HEALTH; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DEMOGRAPHY; DIET SUPPLEMENTATION; DRUG USE; FEMALE; GARLIC; HERBAL MEDICINE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PREVALENCE; REVIEW; SELF REPORT; VITAMIN SUPPLEMENTATION;

EID: 30544449462     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amepre.2005.08.038     Document Type: Article

References (37)

1. Center for Drug Evaluation and Research CDER 1999 report to the nation improving public health through human drugs 1999 U.S. Food and Drug Administration Rockville MD Available at: www.fda.gov/cder/reports/rtn99.pdf. Accessed March 15, 2005
2. S. Levy Mass-merchandisers pull ahead of drugstores in OTC sales Drug Top 17 2000 24
3. Center for Food Safety and Applied Nutrition Dietary supplement strategic plan cost out (report to Congress). Response to House Committee Report 106-619) 2002 U.S. Food and Drug Administration Rockville MD May 29, Available at: www.cfsan.fda.gov/∼dms/ds-stra2.html. Accessed March 15, 2005
4. N. Vuckovic, M. Nichter Changing patterns of pharmaceutical practice in the United States Soc Sci Med 44 1997 1285 1302
5. D.W. Kaufman, J.P. Kelly, L. Rosenberg, T.E. Anderson, A.A. Mitchell Recent patterns of medication use in the ambulatory adult population of the United States. The Slone Survey JAMA 287 2002 337 344
6. L.S. Balluz, S.M. Kieszak, R.M. Philen, J. Mulinare Vitamin and mineral supplement use in the United States. Results from the Third National Health and Nutrition Examination Survey Arch Fam Med 9 2000 258 262
7. A.W. Tsai Cardiovascular disease in Minnesota 2003 report 2003 Minnesota Department of Health St. Paul MN Available at: www.health.state.mn.us/cvh. Accessed March 15, 2005
8. R.V. Luepker, D.R. Jacobs, R.F. Gillum, A.R. Folsom, R.J. Prineas, H. Blackburn Population risk of cardiovascular disease the Minnesota Heart Survey J Chronic Dis 38 1985 671 682
9. J.M. Sprafka, G.L. Burke, A.R. Folsom, R.V. Luepker, H. Blackburn Continued decline in cardiovascular disease risk factors results of the Minnesota Heart Survey, 1980-1982 and 1985-1987 Am J Epidemiol 132 1990 489 500
10. P.G. McGovern, J.S. Pankow, E. Shahar Recent trends in acute coronary heart disease-mortality, morbidity, medical care, and risk factors N Engl J Med 334 1996 884 890
11. D.K. Arnett, P.G. McGovern, D.R. Jacobs Jr Fifteen-year trends in cardiovascular risk factors (1980-1982 through 1995-1997) the Minnesota Heart Survey Am J Epidemiol 156 2002 929 935
12. E.A. Chrischilles, D.J. Foley, R.B. Wallace Use of medications by persons 65 and over data from the Established Populations for Epidemiologic Studies of the Elderly J Gerontol Med Sci 47 1992 M137 M144
13. M. Pahor, M.E. Salive, S.L. Brown Medication use J.M. Guralnik L.P. Fried E.M. Simonsick J.D. Kasper M.E. Lafferty The Women's Health and Aging Study health and social characteristics of older women with disability 1995 National Institute on Aging Bethesda MD (NIH 95-4009). Available at: www.nia.nih.gov/ HealthInformation/Publications/Reports/WomensHealthAgingStudy.html. Accessed March 15, 2005
14. J.A. Landry, M.A. Smyer, J.G. Tubman, D.J. Lago, J. Roberts, W. Simonson Validation of two methods of data collection of self-reported medicine use among the elderly Gerontologist 28 1988 672 676
15. B.M. Psaty, M. Lee, P.J. Savage Assessing the use of medications in the elderly methods and initial experience in the Cardiovascular Health Study J Clin Epidemiol 45 2001 683 692
16. J.T. Hanlon, G.G. Fillenbaum, B. Burchett Drug-use patterns among black and nonblack community-dwelling elderly Ann Pharmacother 26 1992 679 685
17. Brookings Institution Metropolitan Policy Program Minneapolis-St. Paul in focus: a profile from Census 2000 2003 Brookings Institution Metropolitan Policy Program, Living Cities Census Project Washington DC November. Available at: www.brookings.edu/es/urban/livingcities/MinneapolisStPaul.htm. Accessed March 15, 2005
18. D.D. Hermann Naturoceutical agents in the management of cardiovascular disease Am J Cardiovasc Drugs 2 2002 173 196
19. N. Hanyu, C. Simile, A.M. Hardy Utilization of complementary and alternative medicine by United States adults Med Care 40 2002 353 358
20. U.S. Preventive Services Task Force Aspirin for the primary prevention of cardiovascular events recommendations and rationale 2002 Agency for Healthcare Research and Quality Rockville MD January. Available at: www.ahrq.gov/clinic/ 3rduspstf/aspirin/asprr.htm. Accessed March 15, 2005
21. R.S. Eidelman, P.R. Hebert, S.M. Weisman, C.H. Hennekens An update on aspirin in the primary prevention of cardiovascular disease Arch Intern Med 163 2003 2006 2010
22. Center for Drug Evaluation and Research Aspirin for reducing your risk of heart attack and stroke know the facts 2003 U.S. Food and Drug Administration Rockville MD March 13, Available at: www.fda.gov/cder/consumerinfo/ dailyaspirin_brochure.htm. Accessed March 15, 2005
23. P.A. Gum, K. Kottke-Marchant, E.D. Poggio Profile and prevalence of aspirin resistance in patients with cardiovascular disease Am J Cardiol 88 2001 230 235
24. N. Zimmerman, A. Wenk, U. Kim Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery Circulation 108 2003 542 547
25. P.A. Gum, K. Kottke-Marchant, P.A. Welsh, J. White, E.J. Topol A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease J Am Coll Cardiol 41 2003 961 965
26. C. Hur, L.S. Simon, G.S. Gazelle Analysis of aspirin-associated risks in healthy individuals Ann Pharmacother 39 2005 51 57
27. C. Pharand, M.L. Ackman, C.A. Jackevicius, F.L. Paradiso-Hardy, G.J. Pearson Canadian Cardiovascular Pharmacists Network Use of OTC and herbal products in patients with cardiovascular disease Ann Pharmacother 37 2003 899 904
28. U.S. Preventive Services Task Force Routine vitamin supplementation to prevent cancer and cardiovascular disease recommendations and rationale 2003 Agency for Healthcare Research and Quality Rockville MD June, Available at: www.ahrq.gov/clinic/3rduspstf/vitamins/vitaminsrr.htm. Accessed March 15, 2005
29. K.M. Fairfield, R.H. Fletcher Vitamins for chronic disease prevention in adults scientific review JAMA 287 2002 3116 3126
30. K.E. Liede, J.K. Haukka, L.M. Saxén, O.P. Heinon Increased tendency towards gingival bleeding caused by joint effect of alpha-tocopherol supplementation and acetylsalicylic acid Ann Med 30 1998 542 546
31. D.D. Waters, E.L. Alderman, J. Hsia Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women JAMA 288 2002 2432 2440
32. H.D. Reuter Allium sativum and allium ursinum, part 2 pharmacology and medicinal applications Phytomedicine 2 1995 73 91
33. C. Mulrow, V. Lawrence, R. Ackermann Garlic: effects on cardiovascular risks and disease, protective effects against cancer, and clinical adverse effects. AHRQ publication 01-E023 2000 Agency for Healthcare Research and Quality Rockville MD October. Available at: www.ncbi.nlm.nih.gov/books/bv.fcgi? rid=hstat1.chapter.28361. Accessed March 15, 2005
34. N.H. Mashour, G.I. Lin, W.H. Frishman Herbal medicine for the treatment of cardiovascular disease Arch Intern Med 158 1998 2225 2234
35. A. Fugh-Berman Herb-drug interactions Lancet 355 2000 134 138
36. G. Valli, E.G.V. Giardina Benefits, adverse effects and drug interactions of herbal therapies with cardiovascular effects J Am Coll Cardiol 39 2002 1083 1095
37. D.M. Eisenberg, R.B. Davis, S.L. Ettner Trends in alternative medicine in the United States, 1990-1997 results of a follow-up national survey JAMA 280 1998 1569 1575